Mon, February 27, 2023
Sun, February 26, 2023
Sat, February 25, 2023
Fri, February 24, 2023
Thu, February 23, 2023

Raghuram Selvaraju Reiterated (ACRS) at Strong Buy and Held Target at $50 on, Feb 24th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-50-on-feb-24th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy and Held Target at $50 on, Feb 24th, 2023.

Raghuram has made no other calls on ACRS in the last 4 months.



There are 3 other peers that have a rating on ACRS. Out of the 3 peers that are also analyzing ACRS, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $38 on, Tuesday, February 7th, 2023
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $29 on, Wednesday, December 14th, 2022
  • Corinne Jenkins of "Goldman Sachs" Initiated at Strong Buy and Held Target at $25 on, Thursday, December 1st, 2022

Publication Contributing Sources